Organic compounds -- part of the class 532-570 series – Organic compounds – 9,10-seco-cyclopentanohydrophenanthrene ring system or...
Reexamination Certificate
2005-03-15
2005-03-15
Qazi, Sabiha (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
9,10-seco-cyclopentanohydrophenanthrene ring system or...
C514S167000
Reexamination Certificate
active
06867313
ABSTRACT:
Compounds expressed by the following general formula (1),[wherein, R01and R02are each independently a hydrogen atom or a protecting group for a hydroxyl group; Z is one out of the following formulae (1-1) to (1-5)].The compounds can be used as active ingredients of treating agents for inflammatory respiratory diseases, malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
REFERENCES:
patent: 4851401 (1989-07-01), DeLuca et al.
patent: 5354872 (1994-10-01), Conrow
patent: 5583125 (1996-12-01), Steinmeyer et al.
patent: 5604257 (1997-02-01), Tabe et al.
patent: 5719297 (1998-02-01), Tabe et al.
patent: 5986112 (1999-11-01), Tabe et al.
patent: 6028208 (2000-02-01), Gao et al.
patent: 6177586 (2001-01-01), Tabe et al.
patent: 619305 (1994-10-01), None
patent: 2 260 904 (1993-05-01), None
patent: 7-173133 (1995-07-01), None
patent: 11-49747 (1999-02-01), None
patent: 9858909 (1998-12-01), None
Abstract, XP 002226141, JP 08/092,098, Apr. 9, 1996.
Patent Abstracts of Japan, Publication No. 57-149224, Publication date Sep. 14, 1982, abstract.
Patent Abstracts of Japan, Publication No. 56-026820, Publication date Mar. 16, 1981, abstract.
Patent Abstracts of Japan, Publication No. 63-107928, Publication date May 12, 1988, abstract.
Patent Abstracts of Japan, Publication No. 62-026223, Publication date Feb. 4, 1987, abstract.
Patent Abstracts of Japan, Publication No. 05-294834, Publication date Nov. 9, 1993, abstract.
Patent Abstracts of Japan, Publication No. 07-291868, Publication date Nov. 7, 1995, abstract.
The Journal of Clinical Investigation, vol. 64, No. 1, Jul. 1979, pp. 218-225, “Evidence that Increased Circulating 1α25-Dihydroxyvitamin D is the Probable Cause for Abnormal Calcium Metabolism in Sarcoidosis”, Norman H. Bell et al.
Cell Calcium, vol. 16, 1994, pp. 112-122, “Activation of phosphoinositide metabolism by parathyroid hormone in growth plate chondrocytes”, M. J. Zuscik et al.
Calcified Tissue International, vol. 50, 1992, pp. 61-66, “Differential Effects of Parathyroid Hormone on Chick Growth Plate and Articular Chondrocytes”, Ian D. Crabb et al.
Endocrinology, vol. 118, No. 6, 1986, pp. 2445-2449, “Parathyroid Hormone Stimulates the Proliferation of Cells Derived from Human Bone”, B. R. MacDonald et al.
The Journal of Clinical Investigation, vol. 83, Jan. 1989, pp. 60-65, “Insulin-like Growth Factor I Mediates Selective Anabolic Effects of Parathyroid Hormone in Bone Cultures”, Ernesto Canalis et al.
J. Org. Chem., vol. 48, 1983, pp. 4433-4436, “Total Synthesis of 1α25(R)-Dihydroxy Vitamin D326,23(S)-Lactone (Calcitriol Lactone), a Natural Metabolite of Vitamin D3”, Peter M. Wovkulich et al.
Abstract, WO94/07853.
Gao Qingzhi
Ishizuka Seiichi
Manabe Kenji
Sogawa Ryo
Takano Yasuhiro
Qazi Sabiha
Teijin Limited
LandOfFree
Vitamin D3 derivative and treating agent for inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D3 derivative and treating agent for inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D3 derivative and treating agent for inflammatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3379653